Cargando…
The efficacy of PDE5 inhibitors in diabetic patients
BACKGROUND: Phosphodiesterase 5 inhibitors (PDE5i), since their introduction in the late 1990s, have proven their efficacy in treating several conditions, predominantly pulmonary hypertension and erectile dysfunction where they remain the first‐line therapeutic option. However, in the recent years,...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107754/ https://www.ncbi.nlm.nih.gov/pubmed/36367281 http://dx.doi.org/10.1111/andr.13328 |